Pharmalicensing, in partnership with Panel Intelligence, is proud to offer comprehensive Research Partnership tools for Due Diligence Execution.
Panel Intelligence is the first online qualitative market research company and has access to a global network of over 250,000 medical professionals. Advantages include:
Panel Intelligence's research team is experienced in assessing Intellectual Property acquisition for clients including top tier pharmaceutical and biotechnology companies.
Please visit our Due Diligence area to find out further details.
As the springtime counterpart to BIO-Europe, BIO-Europe Spring® continues the tradition of providing life science companies with high caliber partnering opportunities.
Featuring EBD Group's acclaimed partnering system, partneringONETM, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the biotech value chain.
Pharmalicensing now has a sister site focused solely on the generic pharmaceutical industry.
Genericlicensing has been designed in partnership with ICE Pharma Group to offer a unique service to significantly help the business development requirements of the sector.
Genericlicensing also offers a range of partnering and industry services to ‘help the generic industry do business!'
The beta site is now live beta.genericlicensing.com
Strategic divestments of primary care sales focussed brands More
View more in-licensing needs
P38MAPK Inhibitor for Elevation of Hepatic LDL Receptor Levels More
View more out-licensing opportunities
Drug Discovery, Drug Delivery Systems and Medical Devices Research More
SSL International plc is a manufacturer and distributor of healthcare products sold into consumer markets worldwide.
SSL has a diverse portfolio of consumer products which include Durex (condoms and personal lubricants) and Scholl (footcare and footwear).